Skills-based medication training program for patients with schizophrenic disorders: a rater-blind randomized controlled trial

Figures & data

Figure 1 CONSORT diagram.

Table 1 Clinical and sociodemographic details of both study groups

Sociodemographic variables	Intervention group	Control group	Level of significance
Sex (m/f)	27/25	23/27	ns (χ^2=0.36, df=1, P=0.55)
Average age, years	39.8	40.4	ns (t=0.27, df=100, P=0.79)
Living alone	22	18	ns (χ^2=4.14, df=5, P=0.53)
Higher and intermediate educational level	30	31	ns (χ^2=2.68, df=4, P=0.61)
Native language is German	48	45	ns (χ^2=0.20, df=1, P=0.66)
F2-diagnosis of schizophrenia	35	32	ns
Clinical Global Impression Scale: moderate or definitely ill	32	32	ns (Mann–Whitney U=1,132.0, P=0.89)
Average length of stay, days	76.7 (SD: 57.5)	59.4 (SD: 36.4)	ns (t: −1.79, df=100, P=0.07)

Abbreviations: m, male; f, female; SD, standard deviation; ns, not significant.

Table 2 Training days in the different levels of the medication training program

Level of training program at discharge	Patients, n	Training days, arithmetic mean (standard deviation)
2	34 (65.4%)	52.4 (43.6)
3	11 (21.1%)	43.6 (22.6)
4	7 (13.5%)	43.0 (17.4)
2–4	52 (100%)	49.3 (37.2)

Figure 2 Box-whisker plot showing the number of antipsychotics taken out from the dispenser in percent.